COMPASS Pathways plcCMPS stock score: 34/100
$8.65 · +6.53% · Scored Nov 19, 2026
- Technical
- 40
- Fundamental
- 33
- News
- 52
The reading
COMPASS Pathways (CMPS) scores 34 out of 100, which reads bearish, higher than 9% of Healthcare stocks and 10% of the 4,118 US stocks we score.
The composite weights fundamentals 80% and technicals 20%: fundamentals read 33, technicals 40.
Among the fundamentals, Price Target at 100 and Analyst Consensus at 82 score highest, while Free Cash Flow Yield at 0 weighs the most against it.
On the daily chart, trend-following indicators average 20 and contrarian oscillators 67 — a split worth reading before trusting the technical total.
News sentiment is neutral at 52; it is shown, not counted in the composite.
Since Aug 22, 2026 the composite has ranged from 33 to 52, and it is down 14 points over the period.
About COMPASS Pathways
COMPASS Pathways (CMPS) is a London-based biotechnology company developing a psilocybin-based treatment for treatment-resistant depression, a condition affecting patients who have not improved with standard antidepressants. Its candidate, COMP360, is a synthetic, purified form of psilocybin, the active compound in so-called magic mushrooms, given in a single session or a small number of sessions under the supervision of trained therapists in a clinical setting. Two late-stage trials showed that COMP360 reduced depression symptoms compared with a very low control dose, with effects seen quickly and lasting for months in many patients, and the company is seeking U.S. approval. COMPASS has no product revenue and funds development with cash raised from investors, and it is preparing for a potential launch through specialized treatment centers.
COMPASS competes with Johnson & Johnson’s Spravato and with other companies developing psychedelic treatments for depression, including GH Research, AtaiBeckley and MindMed. Its edge rests on being among the first with late-stage data for a psychedelic depression treatment, a large clinical database and patents covering its formulation. Investors who follow CMPS stock tend to watch the regulatory review of COMP360 and launch preparations. Treatment center capacity, reimbursement and the scheduling of psilocybin by federal drug authorities are closely followed. Safety findings, cash runway and the progress of competing psychedelic therapies are other factors.
What’s driving the score
The strongest and weakest of the scorers that count toward CMPS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
33Pulling it up
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
Analyst consensus score synthesizes Wall Street analyst opinions, rating trends, and consensus ratings into a single metric.
Debt-to-Equity ratio measures financial leverage by comparing total debt to shareholder equity.
Holding it back
Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.
Return on Assets (ROA) shows how efficiently a company uses its assets to generate profit.
25 weighted scorers; 14 had no data today and are left out rather than counted as zero.
Technical · daily
26Pulling it up
The price change over the last 52 weeks.
Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
Holding it back
Performance versus SPY compares the stock's returns to the S&P 500 index.
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
Simple Moving Average (100-period) provides a longer-term perspective on price trends.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 52
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 52 | 1 |
| Daily | 26 | 3 |
| Weekly | 38 | 2 |
| Monthly | 55 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Nov 19, 2026 | 34 |
| Nov 18, 2026 | 34 |
| Nov 17, 2026 | 33 |
| Nov 16, 2026 | 34 |
| Nov 15, 2026 | 34 |
| Nov 14, 2026 | 35 |
| Nov 13, 2026 | 37 |
| Nov 12, 2026 | 34 |
| Nov 11, 2026 | 39 |
| Nov 10, 2026 | 39 |
| Nov 8, 2026 | 38 |
| Nov 7, 2026 | 37 |
| Nov 6, 2026 | 37 |
| Nov 5, 2026 | 35 |
| Nov 4, 2026 | 37 |
| Nov 3, 2026 | 37 |
| Nov 2, 2026 | 38 |
| Nov 1, 2026 | 43 |
| Oct 31, 2026 | 43 |
| Oct 30, 2026 | 43 |
| Oct 29, 2026 | 46 |
| Oct 28, 2026 | 45 |
| Oct 27, 2026 | 44 |
| Oct 26, 2026 | 42 |
| Oct 25, 2026 | 42 |
| Oct 24, 2026 | 42 |
| Oct 23, 2026 | 41 |
| Oct 22, 2026 | 43 |
| Oct 21, 2026 | 45 |
| Oct 20, 2026 | 44 |
| Oct 19, 2026 | 42 |
| Oct 18, 2026 | 41 |
| Oct 17, 2026 | 41 |
| Oct 16, 2026 | 40 |
| Oct 15, 2026 | 43 |
| Oct 14, 2026 | 41 |
| Oct 13, 2026 | 41 |
| Oct 12, 2026 | 41 |
| Oct 11, 2026 | 44 |
| Oct 10, 2026 | 44 |
| Oct 9, 2026 | 44 |
| Oct 8, 2026 | 43 |
| Oct 7, 2026 | 44 |
| Oct 6, 2026 | 43 |
| Oct 5, 2026 | 43 |
| Oct 4, 2026 | 43 |
| Oct 3, 2026 | 43 |
| Oct 2, 2026 | 42 |
| Oct 1, 2026 | 43 |
| Sep 30, 2026 | 43 |
| Sep 29, 2026 | 45 |
| Sep 28, 2026 | 46 |
| Sep 27, 2026 | 46 |
| Sep 26, 2026 | 46 |
| Sep 25, 2026 | 46 |
| Sep 24, 2026 | 45 |
| Sep 23, 2026 | 49 |
| Sep 22, 2026 | 50 |
| Sep 21, 2026 | 51 |
| Sep 20, 2026 | 51 |
| Sep 19, 2026 | 51 |
| Sep 18, 2026 | 51 |
| Sep 17, 2026 | 51 |
| Sep 16, 2026 | 48 |
| Sep 15, 2026 | 48 |
| Sep 14, 2026 | 51 |
| Sep 13, 2026 | 50 |
| Sep 12, 2026 | 50 |
| Sep 11, 2026 | 51 |
| Sep 10, 2026 | 50 |
| Sep 9, 2026 | 50 |
| Sep 8, 2026 | 51 |
| Sep 7, 2026 | 49 |
| Sep 6, 2026 | 48 |
| Sep 5, 2026 | 48 |
| Sep 4, 2026 | 47 |
| Sep 3, 2026 | 49 |
| Sep 2, 2026 | 48 |
| Sep 1, 2026 | 47 |
| Aug 31, 2026 | 49 |
| Aug 30, 2026 | 48 |
| Aug 29, 2026 | 48 |
| Aug 28, 2026 | 49 |
| Aug 27, 2026 | 50 |
| Aug 26, 2026 | 52 |
| Aug 25, 2026 | 52 |
| Aug 24, 2026 | 51 |
| Aug 23, 2026 | 49 |
| Aug 22, 2026 | 48 |
Key facts
- Market cap
- $1.2B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Beta
- 2.41
- Risk grade (1–10)
- —
- Next earnings
- Nov 3, 2026
Medical Care Facility peers
| Company | Market cap | Score |
|---|---|---|
| ASTH Astrana Health | $1.4B | 58 |
| USPH U.S. Physical Therapy | $1.4B | 60 |
| AMN AMN Healthcare Services | $1.3B | 51 |
| INNV InnovAge Holding | $1.2B | 57 |
| PNTG The Pennant Group | $1.2B | 63 |
| NUTX Nutex Health | $1.1B | 73 |
Questions
What is CMPS's stock rating today?
CMPS scores 34/100 (Bearish) as of Nov 19, 2026: technical 40, fundamental 33, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.
What does COMPASS Pathways do?
COMPASS Pathways (CMPS) is a London-based biotechnology company developing a psilocybin-based treatment for treatment-resistant depression, a condition affecting patients who have not improved with standard antidepressants. Its candidate, COMP360, is a synthetic, purified form of psilocybin, the active compound in so-called magic mushrooms, given in a single session or a small number of sessions under the supervision of trained therapists in a clinical setting.
Is CMPS stock a buy?
The score is not a buy or sell recommendation. A 34 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the CMPS score calculated?
87 weighted scorers feed it today: 25 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.
Embed this score
A badge for a blog post, newsletter or README. It updates every night and links back here. More badges
HTML
<a href="https://stocksscores.com/stocks/cmps/"><img src="https://stocksscores.com/stocks/cmps/badge.svg" alt="CMPS stock score" height="20"></a>
Markdown
[](https://stocksscores.com/stocks/cmps/)